Form 8-K - Current report:
SEC Accession No. 0001213900-24-106225
Filing Date
2024-12-06
Accepted
2024-12-06 08:34:05
Documents
13
Period of Report
2024-12-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea022382201-8k_synergy.htm   iXBRL 8-K 24593
  Complete submission text file 0001213900-24-106225.txt   195773

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE snyr-20241204.xsd EX-101.SCH 3021
3 XBRL LABEL FILE snyr-20241204_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE snyr-20241204_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT ea022382201-8k_synergy_htm.xml XML 3528
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42374 | Film No.: 241530597
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)